Temporal and spatial compartmentalization of drug-resistant cytomegalovirus (CMV) in a child with CMV meningoencephalitis: Implications for sampling in molecular diagnosis

Journal of Clinical Microbiology

Volumn 51, Issue 12, 2013, Pages 4266-4269

  Frange, Pierre ^a,b   Boutolleau, David ^c   Leruez Ville, Marianne ^a,b   Touzot, Fabien ^a,b,d   Cros, Guilhem ^a,b   Heritier, Sebastien ^a,b   Moshous, Despina ^a,b,d   Neven, Benedicte ^a,b,d   Fischer, Alain ^a,b,d   Blanche, Stephane ^a,b,d  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; DNA POLYMERASE; FOSCARNET; GANCICLOVIR; PHOSPHOTRANSFERASE; VALGANCICLOVIR;

ADENOVIRUS INFECTION; ARTICLE; CASE REPORT; CHILD; CYTOMEGALOVIRUS INFECTION; DRUG WITHDRAWAL; ENCEPHALITIS; GENE MUTATION; GRAFT REJECTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPES SIMPLEX VIRUS 1; HERPETIC STOMATITIS; HUMAN; HUMAN CELL; MALE; MENINGOENCEPHALITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RFXANK GENE; UL54 GENE; UL97 GENE; VIREMIA; VIRUS GENE; VISUAL IMPAIRMENT;

AMINO ACID SUBSTITUTION; ANTIVIRAL AGENTS; BLOOD; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; DRUG RESISTANCE, VIRAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; MALE; MENINGOENCEPHALITIS; POLYMERASE CHAIN REACTION; TIME FACTORS; VIRAL PROTEINS;

EID: 84889867940     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02411-13     Document Type: Article

References (18)

1. Boutolleau D, Deback C, Bressollette-Bodin C, Varnous S, Dhedin N, Barrou B, Vernant JP, Gandjbakhch I, Imbert-Marcille BM, Agut H. 2009. Resistance pattern of cytomegalovirus (CMV) after oral vanganciclovir therapy in transplant recipients at high-risk for CMV infection. Antiviral Res. 81:174-179.
2. Reddy SM, Winston DJ, Territo MC, Schiller GJ. 2010. CMV central nervous system disease in stem-cell transplant recipients: an increasing complication of drug-resistant CMV infection and protracted immunodeficiency. Bone Marrow Transplant. 45:979-984.
3. Seo SK, Regan A, Cihlar T, Lin DC, Boulad F, George D, Prasad VK, Kiehn TE, Polsky B. 2001. Cytomegalovirus ventriculoencephalitis in a bone marrow transplant recipient receiving antiviral maintenance: clinical and molecular evidence of drug resistance. Clin. Infect. Dis. 33:e105-e109.
4. Julin JE, van Burik JH, Krivit W, Webb C, Holman CJ, Clark HB, Balfour HH, Jr. 2002. Ganciclovir-resistant cytomegalovirus encephalitis in a bone marrow transplant recipient. Transpl. Infect. Dis. 4:201-206.
5. Hamprecht K, Eckle T, Prix L, Faul C, Einsele H, Jahn G. 2003. Ganciclovir-resistant cytomegalovirus disease after allogeneic stem cell transplantation: pitfalls of phenotypic diagnosis by in vitro selection of an UL97 mutant strain. J. Infect. Dis. 187:139-143.
6. Wolf DG, Lurain NS, Zuckerman T, Hoffman R, Satinger J, Honingman A, Saleh N, Robert ES, Rowe JM, Kra-Oz Z. 2003. Emergence of late cytomegalovirus central nervous system disease in hematopoietic stem cell transplant recipients. Blood 101:463-465.
7. Zeiser R, Grüllich C, Bertz H, Pantazis G, Hufert FT, Bley TA, Finke J. 2004. Late cytomegalovirus polyradiculopathy following heploidentical CD34-selected hematopoietic stem cell transplantation. Bone Marrow Transplant. 33:243-245.
8. Blackman SC, Lurain NS, Witte DP, Filipovich AH, Groen P, Schleiss MR. 2004. Emergence and compartmentalization of fatal multi-drugresistant cytomegalovirus infection in a patient with autosomal-recessive severe combined immune deficiency. J. Pediatr. Hematol. Oncol. 26:601-605.
9. Miller GG, Boivin G, Dummer JS, McConnell T, Becher MW, Kassim A, Tang YW. 2006. Cytomegalovirus ventriculoencephalitis in a peripheral blood stem cell transplant recipient. Clin. Infect. Dis. 42:e26-e29.
10. Battiwalla M, Paplham P, Almyroudis NG, McCarthy A, Abdelhalim A, Elefante A, Smith P, Becker J, McCarthy PL, Segal BH. 2007. Leflunomide failure to control recurrent cytomegalovirus infection in the setting of renal failure after allogeneic stem cell transplantation. Transpl. Infect. Dis. 9:28-32.
11. Hubacek P, Keslova P, Formankova R, Pochop P, Cinek O, Zajac M, Lochmanova J, Stary J, Sedlacek P. 2009. Cytomegalovirus encephalitis/ retinitis in allogeneic haematopoietic stem cell transplant recipient treated successfully with combination of cidofovir and foscarnet. Pediatr. Transplant. 13:919-922.
12. Candoni A, Simeone E, Buttignol S, Volpetti S, Lazzarotto T, Pipan C, Fanin R. 2011. Late onset cytomeglovirus encephalitis after reducedintensity conditioning allogeneic SCT: an emerging neurological complication? Bone Marrow Transplant. 46:455-456.
13. Jeong TD, Sung H, Choi SH, Lee SO, Yoon HK, Kim MN, Im HJ. 2012. Cytomegalovirus ventriculoencephalitis with compartmentalization of antiviral-resistant cytomegalovirus in a T-cell-depleted haploidentical peripheral blood stem cell transplant recipient. Diagn. Microbiol. Infect. Dis. 74:307-310.
14. Alain S, Hantz S, Scieux C, Karras A, Mazeron MC, Szelag JC, Imbert BM, Fillet AM, Gouarin S, Mengelle C, De Wilde A, Cogne N, Champier G, Rogez S, Legendre C, Denis F. 2004. Detection of ganciclovir resistance after valacyclovir-prophylaxis in renal transplant recipients with active cytomegalovirus infection. J. Med. Virol. 73:566-573.
15. Michel S, Höhn S, Haller T, Jun D, Mertens T. 2001. Aciclovir selects for ganciclovir-cross-resistance of human cytomegalovirus in vitro that is only in part explained by known mutations in the UL97 protein. J. Med. Virol. 65:70-76.
16. Erice A, Borrell N, Li W, Miller WJ, Balfour HH, Jr. 1998. Ganciclovir susceptibilities and analysis of UL97 region in cytomegalovirus (CMV) isolates from bone marrow recipients with CMV disease after antiviral prophylaxis. J. Infect. Dis. 178:531-534.
17. Springer KL, Chou S, Li S, Giller RH, Quinones R, Shira JE, Weinberg A. 2005. How evolution of mutations conferring drug resistance affects viral dynamics and clinical outcomes of cytomegalovirus-infected hematopoietic cell transplant recipients. J. Clin. Microbiol. 43:208-213.
18. Lurain NS, Chou S. 2010. Antiviral drug resistance of human cytomegalovirus. Clin. Microbiol. Rev. 23:689-712.